Asymmetry Capital Management as of Sept. 30, 2020
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 34 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s - Adr (ASND) | 8.1 | $13M | 81k | 154.32 | |
| Insulet Corporation (PODD) | 6.3 | $9.7M | 41k | 236.59 | |
| Quidel Corporation | 5.5 | $8.6M | 39k | 219.39 | |
| Global Blood Therapeutics In | 5.5 | $8.6M | 155k | 55.14 | |
| Guardant Health (GH) | 4.9 | $7.7M | 69k | 111.79 | |
| Cytokinetics (CYTK) | 4.7 | $7.4M | 340k | 21.65 | |
| D Fluidigm Corp Del (LAB) | 4.7 | $7.3M | 978k | 7.43 | |
| Nanostring Technologies (NSTGQ) | 4.6 | $7.2M | 161k | 44.70 | |
| Arena Pharmaceuticals | 4.5 | $7.0M | 93k | 74.80 | |
| Illumina (ILMN) | 4.1 | $6.3M | 21k | 309.08 | |
| Sage Therapeutics (SAGE) | 4.0 | $6.3M | 103k | 61.12 | |
| Kura Oncology (KURA) | 3.9 | $6.1M | 201k | 30.64 | |
| UnitedHealth (UNH) | 3.7 | $5.8M | 19k | 311.74 | |
| Burning Rock Biotech Ltd- Adr | 3.5 | $5.5M | 217k | 25.08 | |
| 10x Genomics Inc Cl A (TXG) | 3.5 | $5.4M | 44k | 124.68 | |
| Fate Therapeutics (FATE) | 2.9 | $4.5M | 113k | 39.97 | |
| Horizon Therapeutics | 2.6 | $4.0M | 52k | 77.68 | |
| Forte Biosciences | 2.5 | $3.9M | 80k | 48.51 | |
| Bristol-myers Squibb-cvr RTS | 2.3 | $3.5M | 1.6M | 2.25 | |
| Antares Pharma | 2.1 | $3.2M | 1.2M | 2.70 | |
| Turning Point Therapeutics I | 2.1 | $3.2M | 37k | 87.36 | |
| Nucana Plc- Adr | 1.7 | $2.7M | 514k | 5.17 | |
| Avadel Pharmaceuticals Adr | 1.7 | $2.6M | 521k | 5.04 | |
| Pacific Biosciences of California (PACB) | 1.6 | $2.5M | 257k | 9.87 | |
| Mei Pharma | 1.6 | $2.5M | 787k | 3.12 | |
| Arcus Biosciences Incorporated (RCUS) | 1.4 | $2.2M | 129k | 17.14 | |
| Fs Dev Corp | 1.4 | $2.2M | 194k | 11.20 | |
| Jazz Pharmaceuticals (JAZZ) | 1.0 | $1.6M | 11k | 142.57 | |
| Iteos Therapeutics (ITOS) | 0.9 | $1.4M | 58k | 24.67 | |
| Graybug Vision | 0.8 | $1.2M | 92k | 12.71 | |
| Novus Therapeutics | 0.7 | $1.0M | 1.1M | 0.95 | |
| Pmv Pharmaceuticals (PMVP) | 0.6 | $884k | 25k | 35.51 | |
| Equillium (EQ) | 0.5 | $828k | 144k | 5.77 | |
| Selecta Biosciences | 0.1 | $137k | 55k | 2.48 |
